The global market for automated breast ultrasound systems was valued at USD 14,24 million in 2023 and is projected to reach USD 2452 million by 2031, expanding at a compound annual growth rate (CAGR) of 12.4% during the forecast period from 2024 to 2031.

Automated Breast Ultrasound (ABUS), a widely adopted technique, has the potential to detect up to 30% more tumors in women with dense breast tissue (more glandular or fibrous than fatty), even if it’s the only additional risk factor. 

For women with denser breasts, mammography may not be sufficient, and ABUS can be utilized to detect more malignancies. Ultrasound procedures do not use ionizing radiation, making ABUS a quick, painless, and efficient method for imaging dense breasts. 

For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/automated-breast-ultrasound-systems-market 

Market Segmentation 

By Ultrasound Type 

By Application 

By End-User 

 View Full Report: https://www.datamintelligence.com/research-report/automated-breast-ultrasound-systems-market 

Market Key Players 

Major players are GE Healthcare, Hitachi, Ltd, Koninklijke Philips N.V., Siemens AG , SonoCiné Inc, Qview Medical, Hologic Inc, Volpara Solutions Limited, Delphinus Medical Technologies, Inc and Nova Medical Inc. 

Trending Reports 

Fertility Monitors Market - https://www.datamintelligence.com/research-report/fertility-monitors-market 

Cardiac Monitoring Devices Market - https://www.datamintelligence.com/research-report/cardiac-monitoring-devices-market 

Brain Monitoring Devices Market - https://www.datamintelligence.com/research-report/brain-monitoring-devices-market 

Ambulatory Blood Pressure Monitors Market - https://www.datamintelligence.com/research-report/ambulatory-blood-pressure-monitors-market